MedTrace Logo

Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome

NCT00200941 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2005-12-16

No results posted yet for this study

Summary

This study is intended to determine whether topiramate is an efficacious and safe treatment for restless legs syndrome.

Conditions

  • Restless Legs Syndrome

Interventions

DRUG

Topiramate

Sponsors & Collaborators

  • Ortho-McNeil Pharmaceutical

    collaborator INDUSTRY

  • Neurocare

    lead OTHER

Principal Investigators

  • Michael P Biber, MD · Neurocare

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-08-31
Completion
2005-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200941 on ClinicalTrials.gov